Supplier sign in
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.


News items September 2020

Post your news
 MTM novel viral transport media successfully evaluated by PHE Patented transport media manufactured by EKF Diagnostics can help to increase COVID-19 testing capacity
MTM novel viral transport media successfully evaluated by PHE
Patented transport media manufactured by EKF Diagnostics can help to increase COVID-19 testing capacity EKF Diagnostics announces that the novel viral transport media PrimeStore® MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE) [1]. To work safely with live SARS-CoV-2 samples requires the use of high-containment laboratories. However, after inactivation SARS-CoV-2 material can be handled at a lower containment level, allowing more laboratories to undertake testing and thereby increasing COVID-19 testing capacity. The PHE study [1] evaluated numerous commercially available reagents and laboratory formulations commonly used for viral inactivation protocols by public health agencies and research laboratories globally. All the reagents tested have been used during the current COVID-19 pandemic for sample transportation and subsequent molecular processing. A total of 23 commercial reagents designed for virus inactivation, clinical sample transportation and nucleic
29-09-2020  |  182x  |  Product news  | 
Widest Choices for 3D Printing Materials by Alfa Chemistry
Widest Choices for 3D Printing Materials by Alfa Chemistry
With the prevalence of 3D printing technology, the demand for 3D printing materials has been increased. Earlier this month, Alfa Chemistry Materials, a professional supplier of various materials and chemicals, announced to provide wide choices of 3D printing materials for customers worldwide. The materials used for 3D printing are diverse, with glass materials, fiber materials, durable nylon materials, gypsum materials, aluminum materials, titanium alloys, stainless steel, silver plating, gold plating and rubber materials to be the most commonly seen ones. Each type has its own unique features, strengths and weaknesses. The final choice is made based on specific needs on different occasions. “Traditionally, as polymeric materials are easy to be manufactured and handled, they have become the focus of 3D printing material industry. However, with the continuous development, great progress has been made,” says a senior scientist from Alfa Chemistry Materials. “Now there
28-09-2020  |  160x  |  Product news  | 
Protheragen Launches Intermediary Services for Biotechnology and Drug R&D
Protheragen Launches Intermediary Services for Biotechnology and Drug R&D
As a provider of one-stop solution for early-stage drug projects, the New York-based company Protheragen recently announced to launch intermediary services, one of its most distinctive businesses, to connect biotechnology and drug R&D companies in an effort to bridge cooperation between the two. Ever since its founding in Ronkonkoma, New York, 2009, Protheragen’s business range has been growing rapidly, which encompasses segments like equity investment and project incubation in addition to intermediary services, providing pharmaceutical licensing opportunities for clients who are interested. To ease communication and improve efficiency, offices have been established at different locations across China and the US. “Relying on our internal database and connection network in the pharmaceutical industry and investment community, we decides to offer intermediary services for companies worldwide, such as assisting high-quality pharmaceutical R&D projects with fundraising,
28-09-2020  |  156x  |  Product news  | 
Italy and India the only pharma economies to improve score International partnering important
Italy and India the only pharma economies to improve score
International partnering important Ahead of the CPhI Festival of Pharma (5-16 October, 2020) – global pharma’s largest ever virtual gathering – the CPhI Pharma Index[i] shows only Italy and India have improved their score in 2020, with the majority of industry executives looking for new supply chain partners. The Index – an aggregated confidence score across the five main small molecule categories in each of the largest economies – compiles the findings from more than 550 executives and sees an overall decrease of 0.86% in score across all nations for the first time. This is perhaps to be expected given the global impact that COVID-19 has had, but overall, the Index shows pharma to be in a strong position and globally, the industry has weathered the impact of the pandemic well. Many of the leading pharma economies have again scored strongly in ‘innovation’ and ‘pharmaceutical quality’ and the slight fall on 2019 results reflects reduced confidence in growth rather than quality. The major exception
28-09-2020  |  139x  |  Industry news  | 
Free Access to Mass Molarity Calculator
Free Access to Mass Molarity Calculator
Alfa Chemistry announces that it now provides free access to a very useful tool—Mass Molarity Calculator for visitors to the website who holds true passion for chemistry and science. As a company famed for supplying quality chemicals of all kinds in the past decade, Alfa Chemistry never stops its efforts in bringing more value out for its customers. Multiple tools were and will be released online for free use. Molarity describes the relationship between moles of a solute and the volume of a solution. The mass molarity calculator tool calculates the mass of compound required to achieve a specific molar concentration and volume. “If you want to dilute a solution of known molarity, please use the Solution Dilution Calculator. And if you want determine the mass required to achieve a specified volume and concentration, then Mass Molarity Calculator would be the right choice,” says one of the senior scientists from Alfa Chemistry. How to Use the Mass Molarity Calculator? Mass,
27-09-2020  |  143x  |  Industry news  | 
Microglia Cells May Promote New Synapse Formation
Through Engulfing Extrace In order to create new memories, the brain cells must first find each other. Small protrusions from the ends of the neurons` long branched antennae connect these neurons together so that they can communicate. The ports where these cells communicate are called synapses, and trillions of synapses are found throughout the brain, which allows us to present new knowledge. However, scientists are still finding out how these connections respond to new experiences and information. In recent years, scientists have discovered that specialized immune cells in the brain, so-called microglia, can help remove unnecessary connections between neurons, possibly by engulfing synapses and breaking them down. Instead, new study found that microglia can also promote the formation of new synapses through the dense protein network between phagocytes, so that neurons can find each other. If scientists continue to study this new role of microglia, they may eventually find new therapeutic targets
26-09-2020  |  105x  |  Industry news
Method for Determination of Drug Permeability
and Its Specific Application Recent advances in chemical synthesis, compound identification, and bioinformatics have multiplied new drug candidates, requiring decisions about molecular potency to be made quickly and accurately. The pharmaceutical industry uses a combination of high-throughput screening (HTS) technology based on the pharmacological activity and pharmacokinetic (PK) properties of a candidate drug. A few years ago, PK properties were the main cause of wastage in drug discovery and development. To overcome this problem, many HTS methods have emerged to optimize the screening phase and help select molecules with the best PK characteristics. These methods are cost-effective and efficient, preventing unnecessary expenditures. The main goal of the pharmaceutical industry is to generate promising molecules based on efficacy, adequate safety, and appropriate PK characteristics, thereby avoiding clinical trial failure. In addition to solubility, most drugs are administered orally, and permeability
26-09-2020  |  111x  |  Industry news
Car-T Cell Therapy — The New Era in Cancer Immunotherapy
Cancer is one of the leading causes of death worldwide. Over the years, many conventional cytotoxic methods for tumor diseases have been developed. However, because of their limited effectiveness based on the heterogeneity of cancer cells, scientists are always looking for treatments with improved results, such as immunotherapy that utilizes and enhances the normal ability of the patient`s immune system. Chimeric antigen receptor (CAR) T cell therapy involves genetic modification of a patient`s own T cells to express a CAR specific for a tumor antigen, which is then expanded in vitro and returned to the patient. Currently, FDA-approved CAR T-cell therapy products are only used in adult B-cell non-Hodgkin`s lymphoma or childhood acute lymphocytic leukemia that have passed two unsuccessful standard treatments. But now clinical trials are beginning to evaluate CAR T-cell therapy as first-line or second-line treatment for adult lymphoma and childhood acute lymphoblastic
26-09-2020  |  145x  |  Industry news
Progress of AAV Gene Therapy
Adeno-associated virus (AAV) is a small, non-enveloped virus that was adapted as a gene transfer vector 30 years ago. It is capable of transducing a variety of species and tissues in vivo without evidence of toxicity, and it produces a relatively mild innate and adaptive immune response. We will analyze the basic biology of AAV, the development history of AAV vector technology, and some clinical and research applications of AAV`s success, as well as the considerations mentioned by researchers. Adeno-associated virus belongs to the family Parvoviridae, is a non-enveloped single-stranded (positive or negative) linear DNA-deficient virus. It is the smallest virus among animal viruses. AAV cannot exist on its own. In the presence of helper viruses such as adenovirus and herpes simplex virus, AAV can replicate and synthesize assembly proteins in infected host cells to produce new virus particles. The main cell entry mechanism of AAV is endocytosis through the use of clathrin-coated
26-09-2020  |  099x  |  Industry news
Gene Editing in Gene Therapy: Current Progress and Future Development Trend
Genome editing technologies, especially those based on zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALENs) and CRISPR/Cas9 are rapidly entering clinical trials. So far, most of the clinical applications of CRISPR have focused on in vitro editing of cells and then reintroducing them into patients. It is very effective for many diseases including cancer and sickle cell disease. But ideal genome editing will also be applied to the body that requires cell modification for diseases. However, the use of CRISPR technology in vivo can be confused by issues such as off-target editing, inefficient or off-target delivery, and stimulation of counterproductive immune responses. Current research on these issues may provide new opportunities for the use of CRISPR in the clinical field. The examination of clinical trial data shows that the number of registered trials using genome editors has increased rapidly, and the selected genome editor has changed
26-09-2020  |  135x  |  Industry news
The Application Prospects of Crispr gene Editing
In a recent study, researchers at the Massachusetts Institute of Technology`s Bode Institute and Harvard University programmed a CRISPR-related enzyme to target three different single-stranded RNA viruses in human embryonic kidney cells ( as well as human lung cancer cells and dog kidney cells) are grown in vitro and minced so that they are largely incapable of infecting other cells. If further experiments indicate that the process is effective for living animals, it may eventually help to identify new antiviral therapies for diseases such as human Ebola or Zika disease. CRISPR is a gene editing technology, a "molecular scissors" that allows scientists to "cut" and "paste" genes into DNA and perform gene editing faster and more accurately. Based on a targeted DNA destruction defense system originally discovered in certain prokaryotes, CRISPR has revolutionized medical science by introducing easy-to-use genome modification methods. CRISPR plays an important role in
26-09-2020  |  108x  |  Industry news
Fastest and safest Planetary Ball Mills on the market Automatic grinding bowl clamping, imbalance control and comminution down to the nano range
Fastest and safest Planetary Ball Mills on the market
Automatic grinding bowl clamping, imbalance control and comminution down to the nano range FRITSCH’s premium line Planetary Ball Mills Pulverisette 5 and 7 can grind, alloy, mix and homogenize reliably at bowl speeds of up to 2200 rpm. They let you effortlessly grind hard, medium, soft, brittle and moist samples down to a final fineness of < 100 nm in a very short time. Sample quantities of 1 to 60 ml (Pulverisette 7) or 15 to 450 ml (Pulverisette 5) can be processed simultaneously at the two grinding stations. The planetary mills premium line work particularly fast thanks to the high bowl speed of up to 2200 rpm and achieve a final fineness of up to < 100 nm in 3 minutes. The easy insertion of the grinding bowls and the blockage of the start in case of impermissible operating conditions make the Planetary Mills in combination with the automatic grinding bowl clamping system particularly user-friendly and safe. For both wet and dry grinding, the process is easy to start due to the guided positioning of the grinding bowl and the automatic bowl detection
25-09-2020  |  118x  |  Product news  | 
NGS Oncology Panels for Cancer Related Research
NGS Oncology Panels for Cancer Related Research
With a high reputation for sequencing, microarray analysis, library construction and genotyping, CD Genomics provides reliable services to pharmaceutical and biotechnology companies as well as academia and government agencies. These days, the product manager of CD Genomics announced that the company has recently optimized NGS oncology panels, which can meet the most challenging research processes. Cancer is a genetic disease, which is induced by the accumulation of harmful DNA mutations in cells. At present, it has been elucidated that the mechanisms of inducing abnormal cell proliferation, differentiation and cancer production are mainly categorized as follows: activating dominant transforming proto-oncogenes by translocations and mutations, inactivating tumor suppressor gene by mutations, and disordering the DNA repair genes. There are two basic types of gene mutations, namely germline mutations and somatic mutations, depending on where the mutation occurs in the
24-09-2020  |  127x  |  Industry news  | 
Protein Interactions Now Available at Creative Enzymes
Protein Interactions Now Available at Creative Enzymes
As an excellent supplier and manufacturer, Creative Enzymes has recently developed several service for researchers working in the life science field. These days, the product manager of Creative Enzymes announces that the company has optimized protein interactions service, which can empower the current knowledge on biochemical cascades and molecular etiology of disease, as well as the discovery of putative protein targets. “We are happy to declare that we have developed our protein interactions service recently, the service will have a better market prospects based on large demands and their specific features.” said senior scientist in Creative Enzymes. Cellular life fundamentally depends on a continuous network of molecular interactions among proteins, nucleic acids, and small molecules. Aberrant interactions are usually the cause of most human diseases such as cancer or autoimmunity. Since proteins rarely act alone as their functions tend to be regulated, the study
24-09-2020  |  118x  |  Industry news  | 
CPhI Middle East & Africa to take place in September 2021
The MENA pharmaceutical market at over $44bn by 2023, with the Saudi market accounting for 24% Abu Dhabi, United Arab Emirates, 23rd September 2020: Informa Markets, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, (CPhI MEA), has announced the 2020 edition of the show will be held alongside the Global Health Exhibition (GHE) in Riyadh, Saudi Arabia on 26-28 September 2021 Under the patronage of HE Dr. Tawfiq Al Rabiah, Saudi Arabia’s Minister of Health, the move to Saudi Arabia and taking place in conjunction with GHE, will create a larger platform for the regional pharma community and underscores the commitment of the country to the global pharmaceutical industry. Sherma Ellis, Brand Manager, CPhI Middle East & Africa, said: “CPhI Middle East & Africa aims to provide the regional pharma community with the optimum platform to grow and do business. After discussions at the highest levels, both internally and externally with our key partners and stakeholders, CPhI Middle East & Africa will now take place in September, alongside
23-09-2020  |  148x  |  Industry news
LabMakelaar: Dupa MSC Microbiological Safety Cabinet Available in 3 sizes
LabMakelaar: Dupa MSC Microbiological Safety Cabinet
Available in 3 sizes A Class II biological safety cabinet offers maximum safety, comfort and ease of use. With an advanced design for easy operation and maximum safety, can be used wherever protection is of great importance. *Operator, product and environmental protection (according to EN 12469; 2000) *Visual and audible alarm at filter saturation *Window (safety glass) electrically adjustable in height, opening 400 mm *UV lighting, including timer *LED lighting, full width *Air cleanliness:> ISO class 4 (class 10) *Optional support frame Available in 3 sizes: -800 x 750 x 1321 mm (WxDxH) -1200 x 750 x 1321 mm (WxDxH) -1800 x 750 x 1321 mm (WxDxH) Contact us if you need more information.
22-09-2020  |  180x  |  Product news  | 
LabForRent: Class 5 Cleanroom (49 m2) 49 m2 cleanroom, located on the Space Business Park near Leiden (NL)
LabForRent: Class 5 Cleanroom (49 m2)
49 m2 cleanroom, located on the Space Business Park near Leiden (NL) The cleanroom is part of the highly representative, recognizable and high-quality office building ‘The Satellite Building’. The entire facility includes various luxury turn-key office rooms (with a terrace), a control room with satellite antenna and a 49m2 cleanroom for rent. The cleanroom is designed as an ISO 5 cleanroom, with a locker room, workspace, furniture and associated technical room. The facility is very conveniently located on the Space Business Park, Noordwijk (NL), a site especially for (aero)space-related companies, directly near ESA-ESTEC (European Space Research and Technology Centre) and Space Expo. The cleanroom is approximately 49m2 in size and complies with ISO class 5. The cleanroom is equipped with: -Locker-room -Compressed air connections -Height-adjustable work tables -Workplace -(Emergency) power -Associated technical room It is up to the tenant to clean the space and request validation. The costs for the first specialist cleaning and validation
22-09-2020  |  176x  |  Industry news  | 
Europital launches as a science-driven full service CRO Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countri
Europital launches as a science-driven full service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countri Europital – a globally-focused full service CRO serving small and mid-tier innovators – announces a significant expansion as it launches new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management, in addition to its existing services of Medical Affairs and Medical Writing. The expanded clinical research offering will see Europital support clients as a full service CRO in over 40 countries from IND through to commercial launch. “We are delighted to announce that we can now provide a full, 360-degree CRO service to innovators in the pharmaceutical, biotechnology and medical devices sectors. Europital has seen a robust expansion in the last few years, and we have been steadily preparing to launch full service capabilities. “It’s no secret, there is a large gap in the CRO industry for these small innovators; what they need is a science-driven CRO that will support them closely with an experienced
22-09-2020  |  124x  |  Industry news  | 
AI & Medicine`s Drug R&D Platform Assists Biomarker Discovery
AI & Medicine`s Drug R&D Platform Assists Biomarker Discovery
On September 15, 2020, AI & Medicine, one of the forerunners in AI-assisted drug research and development, announced that its platform can significantly facilitate biomarker discovery, which is traditionally a very time-consuming and resource-intensive process. Disease biomarker is a molecule that indicates changes in the physiology of a cell under diseased state and hence can be used as a diagnostic tool, therapy monitoring diseases. The demand for new biomarkers is huge in pathology, especially in cancer diagnostics. But traditionally the discovery of fully qualified biomarkers in the medical field is very challenging. It is believed that the combination of liquid biomarker biopsy and AI technology will inevitably improve the accuracy of biomarker discovery. AI & Medicine uses in silico approaches to identify candidate biomarkers indicative of diseases. And this in silico framework is developed based on re-utilization of pre-existing epidemiologic and genetic data.
21-09-2020  |  137x  |  Product news  | 
Artificial Intelligence Is Revolutionizing the Biopharmaceutical Industry
Artificial Intelligence Is Revolutionizing the Biopharmaceutical Industry
Generally speaking, a successful new drug development would entail biopharmaceutical companies $500 million to $1 billion and 10 to 15 years in their drug R&D endeavors. However, though pharmaceutical companies have spent a large sum of money on research and development each year, more than 90% of the molecules discovered using traditional techniques turned out to be failure in human clinical trials. Against such a backdrop, the advent and growing popularity of artificial intelligence (AI) may soon become a major "savior" for maintaining commercial vitality in the pharmaceutical R&D field, and at the same time provide hope for some patients. Some leading AI drug development companies In this long and fierce competition, some companies have chosen different paths, hoping to challenge their limits in unknown areas. Companies focusing on AI-aided drug discovery needs to combine higher levels of traditional biopharmaceutical sciences (biochemistry, biology, biomedicine,
21-09-2020  |  094x  |  Industry news  | 
Application of Artificial Intelligence in SAR Analysis
Application of Artificial Intelligence in SAR Analysis
Statistics show that it usually takes a biopharmaceutical company $500 million to $1 billion and 10 to 15 years to successfully develop a new drug. The high risk, long cycle and high cost of new drug research and development are all big challenges for pharmaceutical companies. AI technology can help analyze the structure-activity analysis of compounds, which can, to some extent, ease the burden of researchers. Artificial intelligence for structure-activity analysis of compounds The structure-activity relationship of a drug refers to the relationship between the chemical activity of the drug and the drug effect. The earliest structure-activity relationship studies qualitatively inferred the relationship between the structure and activity of physiologically active substances in an intuitive way, and then inferred the structure of the active site of the target enzyme and designed new active substance structures. With the development of information technology, computer-assisted
21-09-2020  |  103x  |  Industry news  | 
Chiral Catalysts Are Newly Released at Alfa Chemistry Catalysts
Chiral Catalysts Are Newly Released at Alfa Chemistry Catalysts
As the research on chiral drugs, chiral pesticides and chiral materials continues to be deepened, the demand for optically pure chiral compounds has increased dramatically. To better meet the increasing need arising from the development of chiral synthetic chemistry, the specialized branch of the world’s leading chemical supplier Alfa Chemistry, Alfa Chemistry Catalysts, announced to release a bundle of chiral catalysts for both research and industrial manufacturing use. Chiral catalyst refers to a substance that accelerates a chemical reaction resulting in chiral products from achiral substrates. It plays a pivotal role in some synthetic reactions. Asymmetric catalysis is currently the most effective strategy for chiral synthesis. In particular, enzymes, metal complexes and small organic molecules are three pillar-types of asymmetric catalysts. “By far the best method of synthesis of chiral organic compounds from prochiral substrates is through the use of chiral catalysts
21-09-2020  |  097x  |  Product news  | 
Functional Materials Are Now Accessible at Alfa Chemistry
Functional Materials Are Now Accessible at Alfa Chemistry
Functional materials are materials with specific functions. Earlier this month, Alfa Chemistry Materials announces to provide wide varieties of functional materials for customers worldwide, which could be used in multiples areas and industries like aerospace, biological medicine, environmental ecology and so on. Functional materials are also interpreted as high-tech materials with excellent performances in electrical, magnetic, optical, thermal, acoustic, mechanical, chemical and biological fields. When compared with common structural materials, they generally have other functional properties besides mechanical properties. Applications of Functional Materials Functional materials plays a vital role in not only traditional industries, but also in some newly emerging industries like information technology, biotechnology and energy technology. In this sense, functional materials have diverse application ranges, generally covering aerospace, biological medicine, environmental
21-09-2020  |  101x  |  Product news  | 
Plant Extracts for Cosmetics, Health Food
Plant Extracts for Cosmetics, Health Food
Plant extracts have a long history of being used as drugs or in many other industries like food industry. Alfa Chemistry, located in USA, is committed to proving the best quality chemicals and recently announced to add more plant extracts for both research and industrial use. A plant extract is a substance or active substance of a desired property extracted from plant tissue by treatment for a specific purpose. Plant extracts has multiple functions like anti-irritant, anti-inflammatory, wound healing, anti-infective, sterilization, wetting, etc. Thus, they can be used in a variety of areas such as health foods, therapeutic drugs, cosmetics, processing aids, additives, and many more. “Ever since ancient Egyptian and Roman times, plant extracts have found their application in the treatment of fever and aches. Some of these extracted compounds, such as phenolics and flavonoids, are reported to be effective even in cancer prevention,” says a senior scientist from Alfa
21-09-2020  |  132x  |  Product description  | 
Powerful Instrument Testing Platform at Alfa Chemistry
Powerful Instrument Testing Platform at Alfa Chemistry
Instruments and techniques are of vital importance in analytical testing. To ensure that the most authoritative, reliable and objective reports are provided to the clients, Alfa Chemistry Testing Lab announces the launch of a diversified instrument testing platform, which is widely-encompassing, professional and application-specific. Based on usage and application areas, the instrument testing platform can be classified as the following: Performance Characterization Platform In this platform, instruments like Dissolution Tester, pH/Ion Meter, Specific Surface Area and Pore Size Analyzer, Magnetic Property Measurement System, Aerosol Particle Size Spectrometer, Drop Shape Analyzer, Rockwell Hardness Tester, Nanoparticle Size and Zeta Potential Analyzer, Nano particle Size Analyzer, Wide Range Refractometer, Digital Polarimeter, and Physical Property Measurement System will be employed if needed. Elemental Analysis Platform In this platform, instruments like Carbon
21-09-2020  |  103x  |  Industry news  | 
Protheragen—a Provider of Intermediary Services, Equity Investment
Protheragen—a Provider of Intermediary Services, Equity Investment
To build a bridge between biotechnology and drug R&D companies, Protheragen was founded in Ronkonkoma, New York, 2009. Its mission is to help accelerate the discovery and development of new therapies by combining efforts from researchers and investors to tackle nearly all problems arising from this process. To achieve this, the most fundamental step is to help finance those innovative research projects if they are lacking money. Protheragen’s intermediary service is developed exactly for this purpose. With great expertise and responsibility, Protheragen grows at a fast pace and has achieved a reputation in the industry. However, to better serve the increasing and diversified needs, it decides to broaden its business range by adding the other two services—equity investment and project incubation. And offices have been established at different locations at China and the US so as to improve communication efficiency and conduct relevant research. The three distinctive
21-09-2020  |  138x  |  Industry news  | 
Larotrectinib, First TRK Inhibitor Approved by the FDA for Solid Tumors
Larotrectinib, First TRK Inhibitor Approved by the FDA for Solid Tumors
Larotrectinib approved for solid tumors with NTRK MUTATION On November 26, 2018, the US Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi; Loxo Oncology), the first drug approved for the treatment of adults and pediatric patients with solid tumors that have an NTRK gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed after treatment. Larotrectinib received accelerated approval based on overall response rate and duration of response data. Further clinical trials are required to confirm the clinical benefit of larotrectinib. Commenting on this approval, FDA Commissioner Scott Gottlieb, MD, said, “Today’s approval marks another step in an important shift toward treating cancers based on their tumor genetics rather than their site of origin in the body.” Mechanism of action Larotrectinib is
17-09-2020  |  146x  |  Industry news  | 
ADCs Effectively Targets Surface Protein Of Neuroblastoma In Children
ADCs Effectively Targets Surface Protein Of Neuroblastoma In Children
Physician-scientists in the Cancer Center at Children`s Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells. The researchers published their findings in Science Translational Medicine on Mar. 14, 2019. Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Unlike chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. "If there is an ultimate `bad guy` of neuroblastoma cell surface proteins--present on most tumors, but not on healthy tissues, and also vulnerable to immunotherapeutic targeting--this just may be it," said study leader Yael Mossé, MD, a pediatric oncologist and researcher at Children`s Hospital of Philadelphia (CHOP). "In 2008, we discovered mutations in the anaplastic lymphoma kinase (ALK) gene
16-09-2020  |  137x  |  Industry news  | 
CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacit
Continuous Bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at l Amsterdam, 16 September 2020: CPhI Annual Report – launched ahead of the first CPhI Festival of Pharma (5-16 October, 2020), the world’s largest digital pharma Expo – predicts dramatic growth of new mAb production in China, capacity shortages for cell and gene therapies in the USA, and the widespread global adoption of single-use technologies, but only limited continuous bioprocessing. Three CPhI experts from BioPlan Associates – Vicky Qing XIA, Leo Cai Yang and Eric Langer – explore the rapidly changing global biologics markets, with special reference to the implications for contract outsourcing and China’s continued emergence as a hub for both bio innovation and contract services. Remarkably, China is predicted to continue its rapid bio growth rates, with more than 10 new mAbs predicted to be launched per year in the country by 2025. In fact, the total market size will quadruple by 2025, reaching 120bn RMB, and rising further to 190bn RMB by 2030. “As most
16-09-2020  |  164x  |  Industry news
Probiotics for Industrial and Scientific Research Use
Probiotics for Industrial and Scientific Research Use
Creative Enzymes, a professional and experienced supplier of probiotics, mainly provides enzyme-related products and services. With the continuous expansion of business areas and scale, they have set foot in other areas and established a sound probiotic production and supply chain. Based on high-quality products and services, as well as the unique advantages of large-scale production, its probiotic products are widely favored by industrial customers and scientific research customers. Favorable effects caused by probiotics have been being revealed since the discovery of probiotics. The market of probiotics is rapidly growing due to the increasing demands from the public who are paying more attention to fitness and wellness. A report claims about 1.6 percent of US adults have experience of using probiotics products in the past 30 years. Probiotics are even ranked third in most commonly used dietary supplements other than vitamins and minerals. “Creative Enzymes has a
15-09-2020  |  146x  |  Industry news  | 
Customized Antimicrobial Functional Materials Suitable for Wide Application
Customized Antimicrobial Functional Materials Suitable for Wide Application
For a long time, harmful bacteria have caused great harm to people`s production and life. For example, pathogenic Escherichia coli O157:H7, mad cow disease, foot-and-mouth disease, anthracnose, etc. have caused shocking infections and lead to worries about deterioration of ecological and microbial environment. So countries around the world pay more attention to the research of antibacterial agents. Antibacterial materials are emerging international functional materials in the 1990s. They can provide other materials and products the function of inhibiting and killing microorganisms, and have become an emerging industry worldwide. Creative Diagnostics has long been a leading provider of various kinds of magnetic particles, nanoparticles, quantum dots, beads based kits and devices, etc., now it has expanded the product array to customized antimicrobial functional materials, mainly including: ·Antimicrobial Nanopowder Nano-silver based antimicrobial additives, guanidine-containing
15-09-2020  |  142x  |  Product news  | 
Do I need an Indigo transmitter or just an Indigo probe? Vaisala Indigo family is a modular solution with interchangeable probes, smart transmitters&Indigo Insight.
Do I need an Indigo transmitter or just an Indigo probe?
Vaisala Indigo family is a modular solution with interchangeable probes, smart transmitters&Indigo Insight. The Vaisala Indigo family is a modular solution with interchangeable probes, smart transmitters, and Indigo Insight PC software. There are many probe options to choose from measuring several parameters: humidity, temperature, dew point, carbon dioxide, moisture in oil, and vaporized hydrogen peroxide. The probes can be attached to three different transmitters: the Indigo 201, Indigo 202, and Indigo 520. But when is a probe sufficient on its own – and when do you need both a probe and a transmitter? Indigo-compatible smart probes are based on our well established technology and include everything required to perform measurements – the probes are actually already transmitters. The Indigo-probes have been designed to take users into consideration. Small details are important, for example, standardized cables and an indicator light in the sensor body that shows if the probe is powered. The light also indicates if the communication link is working. When it starts blinking,
15-09-2020  |  233x  |  Product description  | 
Creative BioMart Supports Enzyme and Protein Research with Various Enzymati
Creative BioMart Supports Enzyme and Protein Research with Various Enzymati
Creative BioMart, a biotech company that has always been focusing on developing high quality protein products and efficient protein manufacturing techniques, provides services on enzymatic assays to assist scientists focused on enzyme and protein research. The vast majority of catalytic biological processes are accomplished by enzymes that provide multiple functions in living organisms. They are essential for metabolic processes, cell signaling and regulation, and can produce movement and active transport of molecules. Enzymatic reactions can specifically convert substrate molecules into chemically modified products. These modifications include proteolytic or glycolytic degradation, chemical modifications such as phosphorylation, acylation, glycosylation or oxidative and reductive processes. Dysregulation of enzyme activity can lead to disease states. As a result, enzymes are considered attractive targets for pharmacological intervention in drug therapy. Enzyme activity
15-09-2020  |  159x  |  Product news  | 
DNA Library Preparation Kits to Meet Illumina Sequencing Needs
DNA Library Preparation Kits to Meet Illumina Sequencing Needs
CD Genomics, established in 2004, is aiming at providing the research community with high-quality Next Generation Sequencing products and services. These days, the product manager of CD Genomics announces that the company has recently optimized DNA library preparation kits, which can meet the most challenging research processes. “High-quality nucleic acid purification and library preparation are critical steps in next-generation sequencing (NGS). Our NGS Reagents are complete sets of optimized reagents that are ideal to convert a small amount of DNA / RNA input into indexed libraries for NGS on Illumina platform. Besides, we offer library prep Kits applicable for a variety of NGS applications including whole-genome sequencing (WGS-seq), RNA sequencing (RNA-seq), whole-genome bisulfite sequencing (WGBS), single-cell transcriptome and whole-genome sequencing (scRNA-seq and scWGS-seq), etc, to cater to the customer`s need.” commented vice president of CD Genomics. DNA
14-09-2020  |  133x  |  Industry news  | 
Ocean Insight Launches High-sensitivity NIR Spectrometer New NIRQuest+ spectrometers detect weaker levels of NIR light
Ocean Insight Launches High-sensitivity NIR Spectrometer
New NIRQuest+ spectrometers detect weaker levels of NIR light Ocean Insight, the applied spectral knowledge company, announces the new NIRQuest+ family of NIR spectrometers. NIRQuest+ spectrometers have an enhanced optical bench design for high-sensitivity performance, allowing for low limits of detection at NIR wavelengths from 900-2500. Three versions (900-1700 nm, 900-2200 nm and 900-2500 nm) are available. NIRQuest+ has great thermal stability and can be used in the lab or on the line, such as on a conveyor belt or in a sample stream, as its higher sensitivity allows users to capture the necessary spectra over shorter integration times. Typical applications include detection of moisture content in fruits and grains; identification of plastics for recycling and materials for industry; and monitoring of ingredients in pharmaceutical processes. NIRQuest+ also can measure very small changes in absorbed signal, which are typical of harmonic overtones in the NIR. Its higher sensitivity enables better measurement accuracy, particularly
11-09-2020  |  143x  |  Product news  | 
Topadur pharma AG Selected CDD Vault Platform to Manage Its Research Data
Topadur pharma AG Selected CDD Vault Platform to Manage Its Research Data
ZURICH-Schlieren, Switzerland, Sept. 9, 2020 /PRNewswire/ -- Topadur pharma AG, a clinical stage biopharmaceutical start-up company developing new dual-mode of action drugs that target the cGMP-enzyme regulation system, today announces that it has implemented CDD Vault. The company`s results from drug discovery research programs were successfully digitalized and implemented. CDD Vault is a hosted software platform that manages chemistry and biology data whilst enabling seamless collaboration. CDD Vault is developed by Collaborative Drug Discovery, Inc., a software company headquartered in San Francisco. TOPADUR`s pipeline consists of innovative drug candidates for the treatment of ageing-related diseases. CDD Vault is used as an essential component of the drug development process. It allows Topadur to store, manage and analyze chemical and biological data in a secure way and at the same time share the research information with partners and collaborators. Additionally,
11-09-2020  |  151x  |  Industry news  | 
How Managing Data Effectively Helps Fight Antimicrobial Resistance
How Managing Data Effectively Helps Fight Antimicrobial Resistance
The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial, and companies are teaming up to tackle the growing challenge. But managing collaborative drug discovery data is tough, requiring many small biotechs to rethink how they share and manage their data for antimicrobial development. Andrej Trauner, Project Manager at Swiss biotech BioVersys explains how his company leverages cutting-edge informatics systems to speed up antimicrobial research. See link to full article on Labiotech.
11-09-2020  |  132x  |  Industry news  | 
LabMakelaar topoccasion: Waters Acquity UPLC System As good as new
LabMakelaar topoccasion: Waters Acquity UPLC System
As good as new he Acquity uplc system eliminates significant time and cost per sample from your analytical process while improving the quality of your results. By outperforming traditional or optimized HPLC, this technology allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures. UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and reproducible. What differentiates the holistic design of Acquity uplc systems is Waters’ patented sub-2-μm hybrid particle chemistry, which offers significant benefits over today`s HPLC systems equipped with standard 5-μm particle chemistries. The Acquity uplc system, used on its own or paired with Waters optical and MS detection technologies, provides unique end-to-end solutions for all industries and applications, including: ADME screening, food safety, bioanalysis,
08-09-2020  |  214x  |  Product news  | 
LabForRent: Multi-tenant building focused on biotechnology Planet – Biotech Campus Delft (NL)
LabForRent: Multi-tenant building focused on biotechnology
Planet – Biotech Campus Delft (NL) Planet is a unique scale-up ecosystem focused on industrial biotechnology. Their open innovation campus, centrally located in the Netherlands, welcomes start-ups, SMEs, tech- and service providers, corporates and knowledge institutes to further develop innovative biotech solutions, collaborate and grow together. Planet is a non-profit organisation that contributes to the transition of today’s fossil-based, linear economy to tomorrow’s bio-based, circular economy, by promoting Industrial Biotechnology. They do so by sharing the incredible amount of biotech knowledge and infrastructure available on the Biotech Campus Delft, where they are located. They actively invest in creating a hub in Delft, the Netherlands, where relevant knowledge and networks are shared, and where you will find a professional workspace that inspires you and enables your business to grow. They understand that your business is one of the most important things in your life. They also understand
08-09-2020  |  257x  |  Industry news  | 
Sell your Waters System Labrecycling is searching for used Waters sytems
Sell your Waters System
Labrecycling is searching for used Waters sytems Currently we are searching for Waters Chromatography systems and we are asking for your help. We search among other things: •Waters 2695 •Waters e2695 •Waters Acquity •Waters nanoAcquity UPLC •Waters Acquity UPC2 Convergence Chromatography System •Waters Xevo G2-S Q-TOF MS with Acquity UPLC Labrecycling recycles chromatographic instruments and has room to take over your equipment. Throwing away is a sin. Make your warehouse clear and give your Waters systems a 2nd life.
08-09-2020  |  193x  |  Product news  |   | 
Updated Sensor Solutions website
Sentron pH products in new webshop Dear all, As you know Sentron is a Wellinq company. The Sentron brand has been integrated in the Wellinq portfolio and is now also part of our group webpage. Check and visit our updated Wellinq Sensor Solutions webpage including the new webshop for our ISFET pH meters and probes. Wellinq Sensor Solutions is your partner of choice for sensor integration services, product design, development and realization. Our sensor engineering team makes your product ideas come to live and together with our in house regulatory and clinical experts we ensure rapid market access at the highest quality standards. Besides the services of integration of any sensor into different medical and non-medical devices, we design, provide and sell standard and customized pH products in which we use our own/proprietary ISFET technology. If you have any questions or you want to share your feedback, please do not hesitate to contact us. Sincerely yours, Wellinq Ria Oosterveld Business Development
08-09-2020  |  142x  |  Industry news
First-class Chelating Agents Covering Full Range Are Available First-class Chelating Agents Covering Full Range Are Available at CD Bioparticles
First-class Chelating Agents Covering Full Range Are Available
First-class Chelating Agents Covering Full Range Are Available at CD Bioparticles Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex. They are also known as chelants, chelators, or sequestering agents. Chelating agents have a ring-like center which forms at least two bonds with the metal ion allowing it to be excreted. Due to the rising demand for cleaning formulations, the market will witness a growing trend in the need for chelating agents, which are necessary in the industries of paper & pulp, water treatment, pharmaceuticals, agriculture as well as personal care. To meet the needs of high-quality chelating agents, CD Bioparticles has introduced its comprehensive array of various chelating agents including macrocycles, THP, DFO, TACN, NOTA, DTPA, DOTA, CYCLEN, CYCLAM, 13ANE(n4) and phosphinic derivatives. ·THP Derivatives Tetrahydropyran (THP) is a rigid form of linear ether, thus has lower entropy. As a bioisostere of cyclohexane, THP may gain an additional point of contact with the target
07-09-2020  |  148x  |  Product news  | 
Creative Diagnostics Releases Matched Antigen Pairs Creative Diagnostics Releases Matched Antigen Pairs to Advance Serology Test Development
Creative Diagnostics Releases Matched Antigen Pairs
Creative Diagnostics Releases Matched Antigen Pairs to Advance Serology Test Development Up to August 9, More than 19 million people have tested positive for the novel coronavirus (SARS-CoV-2) globally, and at least 722,000 have died. In the U.S., nearly 5 million people have tested positive and more than 160,000 have died. Since the requirement for specific drugs and vaccines, as well as for effective diagnostic methods, is still urgent, Creative Diagnostics has released matched antigen pairs for serology test development, hoping to race the related research worldwide. Now, a number of false negative results have been reported, resulting in a failure to isolate infected patients. Since titers of SARS-CoV-2 antibodies can reflect the progress of viral infection, consistent clinical manifestations suggested that antibody could act as an indicator of the stage of COVID-19 progression. Creative Diagnostics now provides matched antigen pairs of SARS-CoV-2 Spike/RBD which are expressed in HEK293 cells, mainly covering the following products: ·Recombinant SARS-CoV-2
07-09-2020  |  154x  |  Product news  | 
World’s Largest Virtual Pharma Expo Agenda Unveiled
Former FDA Commission Amsterdam, 03 September 2020: CPhI Festival of Pharma (5-16 October, 2020), the world’s largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda. The newly launched and rapidly created virtual event will provide the global pharma community with a vital platform to meet and exchange ideas – at a time when the industry is still adapting to remote ways of working. The CPhI Festival of Pharma will see global industry heavyweights join forces with more than 20,000 attendees, in what will be a first of its kind virtual pharma gathering designed to meet the needs of the industry in 2021 and beyond. Amongst more than 50 different content sessions, Dr. Scott Gottlieb – Former FDA Commissioner – will use his keynote platform to implore the industry on continuing its efforts towards combining record innovation with affordable healthcare. His seminal talk will explore how the industry can use this moment to implement more sustainable models, increased
03-09-2020  |  182x  |  Industry news
Newsletter archive
Service and contact